Radiofrequency versus Cryoballoon Ablation of Atrial Fibrillation: An Evaluation Using ECG, Holter Monitoring, and Implantable Loop Recorders to Monitor Absolute and Clinical Effectiveness

Table 1

Patient demographic characteristics at baseline.

Patient characteristic	RFC; ()	Cryoballoon; ()	value
Age (mean ± SD)	55.6 ± 12.0	57.6 ± 8.2	0.364
Age > 60 years, (%)	16 (36.4%)	18 (40.0%)	0.828
Male, (%)	19 (43.2%)	22 (48.9%)	0.672
BMI kg/m^2 (mean ± SD)	29.8 ± 4.2	29.9 ± 4.0	0.981
LA diameter, cm (mean ± SD)	4.0 ± 0.4	4.1 ± 0.3	0.129
CHA2DS2-VASc score, (%)
Mean	1.3 ± 1.0	1.3 ± 0.8	0.971
0	11 (25.0%)	7 (15.6%)	0.379
1	14 (31.8%)	20 (44.4%)
2	13 (29.5%)	15 (33.3%)
3	6 (13.6%)	3 (6.7%)
History of TIA, (%)	4 (9.1%)	5 (11.1%)	1.000
IHD, (%)	2 (4.5%)	4 (8.9%)	0.677
Hypertension, (%)	34 (77.3%)	35 (77.8%)	1.000
Diabetic mellitus, (%)	6 (13.6%)	2 (4.4%)	0.157
Drugs, (%)
Antiarrhythmic drugs	44 (100.0%)	45 (100.0%)	1.000
Anticoagulation	44 (100.0%)	45 (100.0%)	1.000